Abstract:Orthogonal recreation of the signaling profile of a chemical synapse is a current challenge in neuroscience. This is due in part to the kinetics of synaptic signaling, where neurotransmitters are rapidly released and quickly cleared by active reuptake machinery. One strategy to produce a rapid rise in an orthogonally controlled signal is via photocaged compounds. In this work, photocaged compounds are employed to recreate both the rapid rise and equally rapid fall in activation at a chemical synapse. Specifically, a complementary pair of photocages based on BODIPY were conjugated to a 5-HT2C subtype-selective agonist, WAY-161503, and antagonist, N-desmethylclozapine, to generate "caged" versions of these drugs. These conjugates release the bioactive drug upon illumination with green light (agonist) or red light (antagonist). We report on the synthesis, characterization, and bioactivity testing of the conjugates against the 5-HT2C receptor. We then characterize the kinetics of photolysis quantitatively using HPLC and qualitatively in cell culture conditions stimulating live cells. The compounds are shown to be stable in the dark for 48 h at room temperature, yet photolyze rapidly when irradiated with visible light. In live cells expressing the 5-HT2C receptor, precise spatiotemporal control of the degree and length of calcium signaling is demonstrated. By loading both compounds in tandem and leveraging spectral multiplexing as a noninvasive method to control local small-molecule drug availability, we can reproducibly initiate and suppress intracellular calcium flux on a timescale not possible by traditional methods of drug dosing. These tools enable a greater spatiotemporal control of 5-HT2C modulation and will allow for more detailed studies of the receptors' signaling, interactions with other proteins, and native physiology.

Caging Bioactive Triarylimidazoles: An Approach to Create Visible Light-Activatable Drugs

Photocages Made to Order: Late-Stage Caging Protocol Enables Anti-Cancer Control with Near-Infrared Light

Design, Synthesis, and Bioevaluation of Novel Reversibly Photoswitchable PI3K Inhibitors Based on Phenylazopyridine Derivatives toward Light-Controlled Cancer Treatment

Photoswitchable Inhibitors to Optically Control Specific Kinase Activity

Coumarin-Derived Caging Groups in the Spotlight: Tailoring Physiochemical and Photophysical Properties

Discovery of a Novel Photoswitchable PI3K Inhibitor Toward Optically-Controlled Anticancer Activity.

A NIR-controlled Cage Mimicking System for Hydrophobic Drug Mediated Cancer Therapy

Photoactivatable Agonist–Antagonist Pair as a Tool for Precise Spatiotemporal Control of Serotonin Receptor 2C Signaling

Elucidating and Optimizing the Photochemical Mechanism of Coumarin-Caged Tertiary Amines

Quantitative control of subcellular protein localization with a photochromic dimerizer

Enzyme‐Activatable Near‐Infrared Hemicyanines as Modular Scaffolds for in vivo Photodynamic Therapy

Harnessing Hypoxia‐Dependent Cyanine Photocages for in Vivo Precision Drug Release

Visible Light Control over the Cytolytic Activity of a Toxic Pore-Forming Protein

A Caged Phosphopeptide‐Based Approach for Photochemical Activation of Kinases in Living Cells

Potent Inhibition and Rapid Photoactivation of Endogenous Bruton’s Tyrosine Kinase Activity in Native Cells Via Opto-Covalent Modulators

Harnessing Radical‐Mediated Photocaged Cyanine under Hypoxia for in vivo Precision Drug Release

Surfing the Limits of Cyanine Photocages One Step at a Time

Bidirectional Regulation of Intracellular Enzyme Activity Using Light‐Driven Nano‐Inhibitors

Spatiotemporal Control of Biology: Synthetic Photochemistry Toolbox with Far-Red and Near-Infrared Light

A Pair of Deep Red Phosphorescent Responsive Emissive Cyclometalated Iridium (III) Complexes as Carbonic Anhydrase Inhibitor and Effective Theranostic Photosensitizer

Self-Assembled Porphyrin-Peptide Cages for Photodynamic Therapy